Segmenting Thoracic Cavities with Neoplastic Lesions: A Head-to-head Benchmark with Fully Convolutional Neural Networks.
Fully Convolutional Neural Network
Lungs with Cancer
segmentation
Journal
ACM-BCB ... ... : the ... ACM Conference on Bioinformatics, Computational Biology and Biomedicine. ACM Conference on Bioinformatics, Computational Biology and Biomedicine
Titre abrégé: ACM BCB
Pays: United States
ID NLM: 101645372
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
ppublish
Résumé
Automatic segmentation of thoracic cavity structures in computer tomography (CT) is a key step for applications ranging from radiotherapy planning to imaging biomarker discovery with radiomics approaches. State-of-the-art segmentation can be provided by fully convolutional neural networks such as the U-Net or V-Net. However, there is a very limited body of work on a comparative analysis of the performance of these architectures for chest CTs with significant neoplastic disease. In this work, we compared four different types of fully convolutional architectures using the same pre-processing and post-processing pipelines. These methods were evaluated using a dataset of CT images and thoracic cavity segmentations from 402 cancer patients. We found that these methods achieved very high segmentation performance by benchmarks of three evaluation criteria, i.e. Dice coefficient, average symmetric surface distance and 95% Hausdorff distance. Overall, the two-stage 3D U-Net model performed slightly better than other models, with Dice coefficients for left and right lung reaching 0.947 and 0.952, respectively. However, 3D U-Net model achieved the best performance under the evaluation of HD95 for right lung and ASSD for both left and right lung. These results demonstrate that the current state-of-art deep learning models can work very well for segmenting not only healthy lungs but also the lung containing different stages of cancerous lesions. The comprehensive types of lung masks from these evaluated methods enabled the creation of imaging-based biomarkers representing both healthy lung parenchyma and neoplastic lesions, allowing us to utilize these segmented areas for the downstream analysis, e.g. treatment planning, prognosis and survival prediction.
Identifiants
pubmed: 35330920
doi: 10.1145/3459930.3469564
pmc: PMC8941645
mid: NIHMS1786943
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIA NIH HHS
ID : R01 AG066749
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003167
Pays : United States
Références
JAMA. 2016 Dec 13;316(22):2402-2410
pubmed: 27898976
Proc IEEE Int Symp Biomed Imaging. 2019 Apr;2019:846-849
pubmed: 31929858
Med Image Anal. 2017 Jan;35:18-31
pubmed: 27310171
Med Image Anal. 2017 Dec;42:60-88
pubmed: 28778026
Med Phys. 2020 Nov;47(11):5941-5952
pubmed: 32749075
Eur Radiol Exp. 2020 Aug 20;4(1):50
pubmed: 32814998
Med Phys. 2018 Oct;45(10):4568-4581
pubmed: 30144101